Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The Development of Novel Disinfectants to Overcome Bacterial Resistance

Award Number: R15AI185860
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/22/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

The Development of Novel Disinfectants to Overcome Bacterial Resistance - Project Summary Bacterial infections cause a tremendous burden to human health, and our first line of defense – amphiphilic disinfectants and antiseptics – rely on century-old technology and are now susceptible to bacterial resistance. This research program has worked for over a decade to develop novel disinfectants, broadly expanding beyond the dogmatic reliance on single-cation amphiphiles like benzalkonium chloride. We aim to capitalize on recent insights, and forge innovations as yet unseen by bacteria. Specifically, we will continue to explore phosphorus-based analogues to traditional disinfectants (quaternary phosphonium compounds or QPCs); work to improve atom economy and mitigate toxicity via innovative structure design; endeavor to better understand how a cationic center (whatever the element) influences bioactivity; and finally broaden our understanding of structure-activity relationships, anchored by specific knowledge of charge density and solution behaviors. While our group has prepared roughly 840 novel disinfectant compounds to date, of first priority will be the construction of an even wider variety of amphiphilic structures. This will take advantage of our recent discoveries in multicationic QPC structure classes, which show the ability to eradicate bacterial strains that have otherwise been deemed pan-resistant. Compounds with bushy-tails – species bearing multiple mid- length alkyl chains – as well as chimeric phosphonium/ammonium hybrids and less-explored bolaamphiphilic structures will be pursued to broaden out structure-activity relationship understanding. We also aim to better understand how the electronic nature of our cationic atom (P vs N) in our amphiphiles can correlate to, and ultimately predict, bioactivity. Charge density analyses (aided by x-ray structure analysis in the lab of Michael Zdilla at Temple University) and Hammett-style electron density- vs-bioactivity plots will enhance our fundamental understanding of how cationic character influences antimicrobial activity and resistance susceptibility. Dynamic surface tension behavior data will be correlated to time-kill observations to further expand the utility of these disinfectants. At the forefront of this research program is the work of undergraduate collaborators, who have been the drivers of our 36 publications in this field, and serve as first authors on 10 of our papers. We envision continuing to employ straightforward chemical syntheses, based on hypothesis-driven rationales. The result is twofold: we are able to learn a great deal about the antibacterial activity of QPC and QAC scaffolds with evaluations of individual structural motifs in a very short period of time, and our students are able to experience interdisciplinary science, as part of a collaborative, multidisciplinary team to advance our knowledge.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $359,073 )
2024	2024	VILLANOVA UNIVERSITY IN THE STATE OF PENNSYLVANIA	800 E LANCASTER AVE	VILLANOVA	PA	19085	DELAWARE	USA	Allergy and Infectious Diseases Research	001	1	7/29/2024	NEW	$35,909
2024	2024	VILLANOVA UNIVERSITY IN THE STATE OF PENNSYLVANIA	800 E LANCASTER AVE	VILLANOVA	PA	19085	DELAWARE	USA	Allergy and Infectious Diseases Research	000	1	7/22/2024	NEW	$323,164
														Subtotal = $359,073

Grand Total All Awards = $359,073

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Development of Novel Disinfectants to Overcome Bacterial Resistance

Award Number: R15AI185860

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/22/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer